lovastatin has been researched along with Leukemia L 1210 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Czyzyk, J; Jakóbisiak, M; Kruszewski, AA; Lasek, W; Malejczyk, J; Sora, MK; Stokłosa, T | 1 |
Engelke, KJ; Hacker, MP | 1 |
2 other study(ies) available for lovastatin and Leukemia L 1210
Article | Year |
---|---|
Synergistic antiproliferative activity of tumor necrosis factor alpha (TNF-alpha) and lovastatin.
Topics: Animals; Antineoplastic Agents; Cell Division; Drug Synergism; Growth Inhibitors; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lamins; Leukemia L1210; Lovastatin; Melanoma, Experimental; Mice; Nuclear Proteins; Proto-Oncogene Proteins c-myc; ras Proteins; Recombinant Proteins; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1994 |
A non-characteristic response of L1210 cells to lovastatin.
Topics: Animals; Cell Cycle; DNA, Neoplasm; G1 Phase; G2 Phase; Kinetics; Leukemia L1210; Lovastatin; Mevalonic Acid; Mice; Mitosis; Protein Prenylation; S Phase; Thymidine; Tumor Cells, Cultured | 1994 |